FIGURE 3.
In vitro evaluation of cell proliferation of exosomes. (A) Relative cell viability of HepG2 after 72 h incubation of HCC exosomes and SD-HCC exosomes; (B) the Annexin V/PI apoptosis assay was measured by FCM analysis of HepG2 cells after being treated with each group for 24 h. n = 3, *** p < 0.001. 1) HepG2, 2) HepG2 + HCC exosome, 3) HepG2 + SD-HCC exosome, 4) HepG2 + SD-HCC exosome + CTLA-4 inhibitor.
